Ashton Thomas Securities’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$599K Buy
1,683
+504
+43% +$173K 0.09% 193
2026
Q1
$415K Buy
1,179
+159
+16% +$56.7K 0.05% 265
2025
Q4
$334K Sell
1,020
-132
-11% -$41.9K 0.06% 204
2025
Q3
$326K Buy
1,152
+416
+57% +$121K 0.05% 261
2025
Q2
$205K Sell
736
-28
-4% -$7.93K 0.05% 237
2025
Q1
$238K Sell
764
-46
-6% -$13.6K 0.07% 208
2024
Q4
$206K Buy
810
+50
+7% +$14.8K 0.06% 219
2024
Q3
$245K Buy
+760
New +$249K 0.05% 240

Other funds holding AMGN

Ashton Thomas Securities's AMGN Position: Q2 2026 in Review

Ashton Thomas Securities increased its Amgen (AMGN) stake by 43% in Q2 2026, buying an estimated $173K and bringing the position to 1,683 shares worth $599K. The position accounts for 0.09% of the portfolio, ranked #193.

Ashton Thomas Securities first reported a position in AMGN in Q3 2024 and has held it in 8 quarters since. 3,139 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Ashton Thomas Securities held 1,683 shares of Amgen worth $599K as of Q2 2026.
  • Ashton Thomas Securities bought 504 Amgen shares in Q2 2026, an estimated $173K.
  • Amgen made up 0.09% of Ashton Thomas Securities's portfolio in Q2 2026, its #193 holding.
  • Ashton Thomas Securities first reported a position in Amgen in Q3 2024 and has held it in 8 quarters since.
  • 3,139 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Ashton Thomas Securities's 13F filing for Q2 2026, filed 27 Jul 2026.